Pharma positions itself for 2026 amid an evolving US landscape
From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026?
Altimmune reports positive topline results from IMPACT Phase IIb trial
Psyence gains HREC nod to use PsyLabs’ psilocybin in adjustment disorder trial
Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs
Takeda to seek approval of plaque psoriasis pill on Phase III trial data
Soligenix reports Phase IIa SGX945 trial data for Behçet’s disease
Analysis
View More
Themes
View MoreRevealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
91% of clinical research associates concerned with burnout and turnover, third-party data query resolution can cost sponsors millions.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View more
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Patient-centric approaches thrive on wearables and remote access in trials
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment